Metabolic manipulation in chronic heart failure: study protocol for a randomised controlled trial

BACKGROUND: Heart failure is a major cause of morbidity and mortality in society. Current medical therapy centres on neurohormonal modulation with angiotensin converting enzyme inhibitors and β-blockers. There is growing evidence for the use of metabolic manipulating agents as adjunctive therapy in...

Descripción completa

Detalles Bibliográficos
Autores principales: Beadle, Roger M, Williams, Lynne K, Abozguia, Khaild, Patel, Kiran, Leon, Francisco Leyva, Yousef, Zaheer, Wagenmakers, Anton, Frenneaux, Michael P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3125337/
https://www.ncbi.nlm.nih.gov/pubmed/21645332
http://dx.doi.org/10.1186/1745-6215-12-140

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3125337/
https://www.ncbi.nlm.nih.gov/pubmed/21645332
http://dx.doi.org/10.1186/1745-6215-12-140

Ejemplares similares